Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,947,441
+$44,965 QoQ
Shares Held
7,668
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#2,372
of 4,664 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pitcairn Wealth Advisors LLC holds $9,955,326 across 8 Drug Manufacturers - General names. JNJ ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,293 | $3,949,723 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
7,668 | $1,947,441 | |
| 3 | ABBV |
AbbVie Inc.
|
4,269 | $1,074,251 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
14,740 | $849,318 | |
| 5 | AMGN |
Amgen Inc
|
2,256 | $816,942 | |
| 6 | BIIB |
Biogen Inc.
|
3,010 | $650,340 | |
| 7 | PFE |
Pfizer Inc
|
14,921 | $359,297 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,397 | $308,014 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,947,441 | 7,668 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,902,476 | 7,783 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,610,898 | 7,784 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||